{'52WeekChange': 'Infinity',
 'SandP52WeekChange': None,
 'address1': '142 Sansome Street',
 'address2': 'Second Floor',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 31.88,
 'askSize': 800,
 'averageDailyVolume10Day': 72087,
 'averageVolume': 94425,
 'averageVolume10days': 72087,
 'beta': None,
 'beta3Year': None,
 'bid': 30.1,
 'bidSize': 1200,
 'bookValue': -88.3,
 'category': None,
 'circulatingSupply': None,
 'city': 'San Francisco',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 32.53,
 'dayLow': 30.81,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -10.815,
 'enterpriseToRevenue': None,
 'enterpriseValue': 351319488,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 27.485,
 'fiftyTwoWeekHigh': 47.253,
 'fiftyTwoWeekLow': 14,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 3802967,
 'forwardEps': -3.47,
 'forwardPE': -9.1268015,
 'fromCurrency': None,
 'fullTimeEmployees': 22,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0,
 'heldPercentInstitutions': 1.0376999,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/89bio.com',
 'longBusinessSummary': '89bio, Inc., a clinical-stage biopharmaceutical '
                        'company, focuses on the development and '
                        'commercialization of various therapies for the '
                        'treatment of liver and cardio-metabolic diseases. The '
                        "company's lead product candidate is BIO89-100, an "
                        'engineered glycoPEGylated analog of fibroblast growth '
                        'factor 21 that is in proof of concept Phase 1b/2a '
                        'clinical trial in patients with nonalcoholic '
                        'steatohepatitis (NASH) or nonalcoholic fatty liver '
                        'diseases with a high risk of NASH. 89bio, Inc.was '
                        'founded in 2018 and is headquartered in San '
                        'Francisco, California.',
 'longName': '89bio, Inc.',
 'market': 'us_market',
 'marketCap': 533709184,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_640272057',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -63525000,
 'nextFiscalYearEnd': 1640908800,
 'open': 32.23,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.68,
 'phone': '415 500 4614',
 'previousClose': 32.78,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 32.53,
 'regularMarketDayLow': 30.81,
 'regularMarketOpen': 32.23,
 'regularMarketPreviousClose': 32.78,
 'regularMarketPrice': 32.23,
 'regularMarketVolume': 29000,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 16852200,
 'sharesPercentSharesOut': 0.0561,
 'sharesShort': 774159,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 558864,
 'shortName': '89bio, Inc.',
 'shortPercentOfFloat': 0.19309999,
 'shortRatio': 12.33,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'ETNB',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -72.334,
 'twoHundredDayAverage': 27.362555,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '6271fd18-e443-39f3-b14c-3361d6248f55',
 'volume': 29000,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.89bio.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '94104'}